StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

ISRGBearishEarningsnews
High materiality8/10

ISRG Q3 Beat; 2026 Growth Guidance Raised, Shares Retreat After Earnings

Oct 21, 2026, 10:13 AM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting

Near-term execution-driven stock move due to earnings beat offset by post-earnings PT revisions and a 5.8% drop; valuation remains sensitive to how 2026 guidance translates into cash flow and margin realization.

AI summary

What happened, with direct paths to the underlying reporting

Intuitive Surgical beat on revenue and earnings due to broad adoption across da Vinci platforms. The company guided 2026 worldwide da Vinci procedures to grow 14-15% with margins around 68.7-69.3%, supporting durable profitability. However, shares declined about 5-6% as investors digest changes to price targets from several analysts.

  • ISRG Q3 revenue $3.05B, above $2.91B estimate.
  • Q3 adjusted EPS $3.00, vs $2.64 estimate.
  • 2026 da Vinci procedures growth guided to 14-15%; gross margin 68.7-69.3%.
  • Shares fell 5.8% to $413.12 after results; multiple PT revisions.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.